This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) rose 1.05% to $151.74 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.89% to 3,957.25 and Dow Jones Industrial Average falling 0.63% to 33,536.70. This was the stock's third consecutive day of gains. AbbVie Inc. closed $24.17 below its 52-week high ($175.91), which the company reached on April 8th.
The stock underperformed when compared to some of its competitors Monday, as Pfizer Inc. (PFE) rose 3.45% to $49.24, Eli Lilly & Co. (LLY) rose 1.35% to $356.06, and AstraZeneca PLC ADR (AZN.LN) rose 1.82% to $63.91. Trading volume (7.0 M) eclipsed its 50-day average volume of 5.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 14, 2022.
(END) Dow Jones Newswires
November 14, 2022 16:33 ET (21:33 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.